Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Opioid analgesics for nociceptive cancer pain: A comprehensive review.
Abdel Shaheed C, Hayes C, Maher CG, Ballantyne JC, Underwood M, McLachlan AJ, Martin JH, Narayan SW, Sidhom MA. Abdel Shaheed C, et al. Among authors: sidhom ma. CA Cancer J Clin. 2024 May-Jun;74(3):286-313. doi: 10.3322/caac.21823. Epub 2023 Dec 18. CA Cancer J Clin. 2024. PMID: 38108561 Free article. Review.
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502).
Weickhardt A, Foroudi F, Lawrentschuk N, Xie J, Sidhom M, Pal A, Grimison P, Zhang A, Ng S, Tang C, Hovey E, Chen C, Hruby G, Guminski A, McJannett M, Conduit C, Tran B, Davis ID, Hayne D. Weickhardt A, et al. Among authors: sidhom m. Eur Urol Oncol. 2024 Jun;7(3):469-477. doi: 10.1016/j.euo.2023.09.011. Epub 2023 Oct 7. Eur Urol Oncol. 2024. PMID: 37806844 Clinical Trial.
Predicting regional control based on pretreatment nodal size in squamous cell carcinoma of the head and neck treated with chemoradiotherapy: a clinician's guide.
Porceddu SV, Sidhom M, Foote M, Burmeister E, Stoneley A, El Hawwari B, Milross C, Kenny L, Poulsen M, Coman WB. Porceddu SV, et al. Among authors: sidhom m. J Med Imaging Radiat Oncol. 2008 Oct;52(5):491-6. doi: 10.1111/j.1440-1673.2008.02001.x. J Med Imaging Radiat Oncol. 2008. PMID: 19032396
A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.
Pearse M, Fraser-Browne C, Davis ID, Duchesne GM, Fisher R, Frydenberg M, Haworth A, Jose C, Joseph DJ, Lim TS, Matthews J, Millar J, Sidhom M, Spry NA, Tang CI, Turner S, Williams SG, Wiltshire K, Woo HH, Kneebone A. Pearse M, et al. Among authors: sidhom m. BJU Int. 2014 Mar;113 Suppl 2:7-12. doi: 10.1111/bju.12623. BJU Int. 2014. PMID: 24894850 Clinical Trial.
Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques.
Duchesne GM, Haworth A, Bone E, Carter H, Ebert MA, Gagliardi F, Gibbs A, Hornby C, Martin A, Sidhom M, Wood M, Jackson M. Duchesne GM, et al. Among authors: sidhom m. J Med Imaging Radiat Oncol. 2016 Feb;60(1):129-37. doi: 10.1111/1754-9485.12390. Epub 2015 Oct 5. J Med Imaging Radiat Oncol. 2016. PMID: 26439588
93 results